By Peace Udugba -The daily torch media
The Federal Government of Nigeria has announced plans to roll out a groundbreaking HIV prevention drug, Lenacapavir, across eight states in a major step toward curbing new infections.
Health authorities disclosed that the initiative will introduce the long-acting injectable drug—administered just twice a year—as part of a broader strategy to strengthen HIV prevention efforts, particularly among high-risk populations.
Lenacapavir, recently approved in some countries for HIV treatment and prevention trials, is being hailed as a potential game-changer due to its convenience compared to daily oral pre-exposure prophylaxis (PrEP) pills.
Experts say the biannual injection could significantly improve adherence and reduce the rate of new infections.
A senior official from the Federal Ministry of Health said the rollout would begin in selected states with higher HIV burden and strategic healthcare infrastructure to support the programme. The states are expected to be announced as implementation plans are finalised.
The initiative is being supported by global health partners, including the World Health Organization and UNAIDS, alongside other donor agencies working to end the HIV epidemic.
According to health experts, Nigeria remains one of the countries with a significant number of people living with HIV, making innovative prevention tools critical. The introduction of Lenacapavir is expected to complement existing interventions such as condom use, testing, and antiretroviral therapy.
Public health advocates have welcomed the move, noting that easier-to-use preventive options could help reach underserved and vulnerable communities, including young people and key populations.
The Federal Government reiterated its commitment to reducing new HIV infections and achieving epidemic control, stating that the Lenacapavir rollout represents a bold step toward a healthier future for Nigerians.
